BiotechTube

Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rotavirus Gastroenteritis

Conditions

Rotavirus Gastroenteritis

Trial Timeline

Sep 1, 2009 → Mar 1, 2010

NCT ID
NCT00953056

About Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo

Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo + Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Placebo is a phase 1 stage product being developed by Merck for Rotavirus Gastroenteritis. The current trial status is completed. This product is registered under clinical trial identifier NCT00953056. Target conditions include Rotavirus Gastroenteritis.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00953056Phase 1Completed

Competing Products

14 competing products in Rotavirus Gastroenteritis

See all competitors
ProductCompanyStageHype Score
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP) + Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)MerckPhase 3
77
RotaTeq™, rotavirus vaccine, live, oral, pentavalent + Comparator: Placebo matching RotaTeq™MerckPhase 3
77
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: Oral Poliovirus Vaccine (OPV) + Comparator: Oral Poliovirus Vaccine (OPV) (staggered)MerckPhase 3
77
RotaTeq (V260) + IPVMerckPhase 3
77
Rotateq™ + Comparator: PlaceboMerckPhase 3
77
RotaTeq™ (V260) + DTP-IPVMerckApproved
85
Comparator: RotaTeq + Comparator: Placebo + Comparator: RotaTeq + PlaceboMerckPhase 1
33
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: PlaceboMerckPhase 3
77
V260 + Placebo to V260 + OPV + DTaPMerckPhase 3
77
rotavirus vaccine, live, oral, pentavalent + PlaceboMerckPhase 3
77
Rotavirus Vaccine, Live, Oral, Pentavalent + Comparator: placebo + Comparator: Infanrix(tm) HexaMerckPhase 3
77
RotaTeq™ experimental formulation + RotaTeq™ existing formulationMerckPhase 3
77
Rotarix + RotaTeqMerckPhase 3
77
Rotavirus Vaccine, Live, Oral, Pentavalent (V260, RotaTeq™) + Comparator: Comparator: Placebo (unspecified)MerckPhase 3
77

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85